← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
376	First Manhattan New York	$20.9M	-$8.78M	8	0.08%	Reduced
377	NM Newtyn Management New York	$20.8M	-$11.5M	4	4.91%	Reduced
378	British Columbia Investment Management Victoria, British Columbia, Canada	$20.7M	+$16.7K	4	0.19%	Increased
379	AQR Arbitrage Greenwich, Connecticut	$20.6M	+$13.5M	4	0.89%	Increased
380	Peregrine Capital Management Minneapolis, Minnesota	$20.5M	-$3.57M	4	0.56%	Reduced
381	AssetMark Inc Concord, California	$20.4M	+$988K	5	0.08%	Increased
382	Curi RMB Capital Chicago, Illinois	$20.2M	-$1.03M	7	0.66%	Reduced
383	Capital Advisors Inc Tulsa, Oklahoma	$20.2M	+$3.19M	2	0.51%	Increased
384	CM Crestline Management Fort Worth, Texas	$20.1M	+$659K	1	2.09%	Increased
385	AGP Artia Global Partners Miami, Florida	$19.9M	+$4.07M	3	6.87%	Increased
386	GGI Godsey & Gibb Inc Richmond, Virginia	$19.9M	-$651K	1	2.26%	Reduced
387	WIC Water Island Capital New York	$19.8M	+$17.8M	1	1.7%	New
388	Douglas Lane & Associates New York	$19.7M	-$1.31M	2	0.32%	Reduced
389	Simplex Trading Chicago, Illinois	$19.6M	+$10.8M	41	0.02%	Increased
390	LIC Laurus Investment Counsel Toronto, Canada	$19.6M	-$29.8K	1	7.04%	Reduced
391	Reinhart Partners Mequon, Wisconsin	$19.6M	-$86.2K	1	0.99%	Reduced
392	Profund Advisors Bethesda, Maryland	$19.5M	-$1.18M	21	1.05%	Reduced
393	BCAM Boston Common Asset Management Boston, Massachusetts	$19.5M	-$102K	1	0.42%	Reduced
394	Kennedy Capital Management St Louis, Missouri	$19.4M	-$655K	1	0.45%	Reduced
395	TC TwinBeech Capital Purchase, New York	$19.4M	-$10.1M	6	0.38%	Reduced
396	HTHT Hemenway Trust Hemenway Trust Salem, New Hampshire	$19.4M	+$481K	1	1.9%	Increased
397	TOTUOP Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania	$19.1M	$0	1	14.43%	Maintained
398	SG Americas Securities New York	$18.9M	-$5.87M	12	0.14%	Reduced
399	IBT International Biotechnology Trust London, United Kingdom	$18.8M	-$23.1M	8	5.72%	Reduced
400	Davidson Kempner Capital Management New York	$18.8M	+$10.9M	1	0.36%	Increased